Nature Medicine, Published online: 03 September 2026; doi:10.1038/d41591-026-00045-z
The first approved PROTAC for breast cancer validated the idea that medicines can work by bringing proteins together rather than by simply blocking them. Now, a new generation of proximity-based therapies is pushing that principle further.
